ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,808.71
-0.38%
S&P 500
5,352.96
-0.02%
Dow Jones
38,886.17
0.20%
US Dollar vs Yen
155.644
-0.19%
Brent Oil
79.88
1.68%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) ニュース

ANIP

ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ANIP
日付受信時刻ニュースソース見出しコード企業名
2024/06/0707 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/06/0620 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/06/0520 : 59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
2024/06/0507 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/06/0505 : 35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/3005 : 30GlobeNewswire Inc.ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2409 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2409 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2408 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2408 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2408 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2405 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2307 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2206 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2105 : 57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2019 : 50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Kionex® SuspensionNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1807 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1807 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1805 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1706 : 02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1706 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1705 : 49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1605 : 59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1508 : 47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1505 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1406 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1020 : 09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1019 : 55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1019 : 50GlobeNewswire Inc.ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 GuidanceNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/0205 : 30GlobeNewswire Inc.ANI Pharmaceuticals to Participate at Two Upcoming Healthcare ConferencesNASDAQ:ANIPANI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ANIP

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
NASDAQ
MSFT
Microsoft
NYSE
BAC
Bank of America
NYSE
VZ
Verizon Communications
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
CCOM
US30
US 30
CCOM
US100
US Tech 100
NYSE
AXP
American Express
CCOM
US500
US 500
NYSE
MRK
Merck
FX
USDEUR
US Dollar vs Euro
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有